Research programme: nicotinamide phosphoribosyltransferase modulators - CalicoAlternative Names: NAMPT modulators - Calico; P7C3 aminopropyl carbazloes - Calico
Latest Information Update: 17 Sep 2014
At a glance
- Originator University of Texas Southwestern Medical Center
- Developer Calico
- Class Carbazoles
- Mechanism of Action Nicotinamide phosphoribosyltransferase modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurodegenerative disorders